ArticleVirchows Archiv : an international journal of pathology2025
Computer-aided tumor cell fraction (TCF) estimation by medical students, residents, and pathologists improves inter-observer agreement while highlighting the risk of automation bias.
Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A guide for the deployment, validation, and accreditation of clinical digital pathology tools.Journal of pathology informatics · 2026Article
- [The problem of determining tumor cell content].Pathologie (Heidelberg, Germany) · 2026Article
- The critical role of accurate neoplastic cell percentage (NCP) assessment: investigating targeted training strategies for pulmonary biopsy and cytology specimens.Virchows Archiv : an international journal of pathology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential for computer-aided diagnostics (CAD) to augment learning outcomes for medical education in histopathology are vast. However, over-reliance in CAD tools could lead to important errors if the output is inaccurate, such as automation bias. Here, we analyze the influence of a CAD tool for tumor cell fraction (TCF) estimation, named TCFCAD, on medical students with limited histopathological expertise, compared to pathology residents and practicing pathologists. Participants were third-year medical students from the University of Bern (n = 18), residents and pathologists from the European Masters in Molecular Pathology (EMMP; n = 23), and 63 practicing pathologists stratified by < 20 or > 20 years of professional experience (n = 28 and 32, respectively). Each group evaluated 10 colorectal cancer regions of interest (ROI) with and without TCFCAD assistance. The ground truth (GT) was evaluated by a laborious count of all tumor and non-tumor cells per ROI. All groups demonstrated reduced variability in TCF scores with TCFCAD assistance. The standard deviation (SD) of the TCF scores compared to the GT values before and after TCFCAD assistance were 9.09 to 4.95 for medical students, 9.93 to 5.55 for EMMP, and 9.98 to 5.69 and 9.9 to 6.13 for pathologists with < 20 and > 20 years of experience. For one image, both medical students and EMMP participants' scores swayed to the TCFCAD's output despite (1) tool output being inaccurate and (2) participants' original scores without TCFCAD assistance being closer to the GT value. This confirmed a trend of medical students following the tool's recommendation across all ROIs. All groups benefitted most from TCFCAD output for a tumor with marked inflammatory infiltrates. Although TCFCAD improved interobserver agreement, independently of professional experience, there is a demonstrated danger in over-relying on its output. This important bias must be addressed when training students and pathologists on the use of CAD tools.
Indexed as
Identifiers
40610733What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.